| Literature DB >> 23176976 |
Flor M Munoz1, Patricia Ferrieri.
Abstract
A group B streptococcus vaccine for pregnant women would add to the currently available vaccines given during pregnancy to protect mothers and their infants against serious and potentially lethal diseases, including tetanus, influenza, pertussis and meningococcal infection. Implementation of the administration of these high priority vaccines during routine prenatal care would result in a maternal immunization program with the potential to have a positive impact in public health globally, by reducing maternal and neonatal morbidity and mortality.Entities:
Keywords: AAFP; AAP; ACIP; ACOG; Advisory Committee on Immunization Practices; American Academy of Family Practice; American Academy of Pediatrics; American College of Obstetrics and Gynecology; CDC; Centers for Disease Control and Prevention; EPI; Extended Program on Immunization; GACVS; GAVI; GBS; Global Advisory Committee on Vaccine Safety; Global Alliance for Vaccines and Immunisation; Global program; Group B streptococcus; MNT; Maternal immunization; Maternal-Neonatal Tetanus; Neonates; Pregnancy; Vaccine; WHO; World Health Organization
Mesh：
Substances：
Year: 2012 PMID： 23176976 DOI： 10.1016/j.vaccine.2012.11.026
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641